Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation

Detalhes bibliográficos
Autor(a) principal: Shaheen, Nabeela
Data de Publicação: 2018
Outros Autores: Zaman, Shahiq uz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/159059
Resumo: Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile.
id USP-31_be380e742691d6e7f2ec1ff80e06b8f6
oai_identifier_str oai:revistas.usp.br:article/159059
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluationFlurbiprofen/dissolutionFast dissolving tabletsDrug releaseSublimating agentSuperdisintegrantFlurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15905910.1590/s2175-97902018000417061Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17061Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17061Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e170612175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/159059/153987Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccessShaheen, NabeelaZaman, Shahiq uz2019-06-24T20:15:38Zoai:revistas.usp.br:article/159059Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-06-24T20:15:38Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
title Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
spellingShingle Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
Shaheen, Nabeela
Flurbiprofen/dissolution
Fast dissolving tablets
Drug release
Sublimating agent
Superdisintegrant
title_short Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
title_full Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
title_fullStr Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
title_full_unstemmed Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
title_sort Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation
author Shaheen, Nabeela
author_facet Shaheen, Nabeela
Zaman, Shahiq uz
author_role author
author2 Zaman, Shahiq uz
author2_role author
dc.contributor.author.fl_str_mv Shaheen, Nabeela
Zaman, Shahiq uz
dc.subject.por.fl_str_mv Flurbiprofen/dissolution
Fast dissolving tablets
Drug release
Sublimating agent
Superdisintegrant
topic Flurbiprofen/dissolution
Fast dissolving tablets
Drug release
Sublimating agent
Superdisintegrant
description Flurbiprofen belongs to Biopharmaceutical Classification System (BCS) class II drugs which are poorly soluble in water. The objective of present research work was to prepare fast dissolving tablets of Flurbiprofen using varying concentrations of three different sublimating agents to improve the dissolution rate. Seven formulations were prepared containing different concentrations of camphor, ammonium bicarbonate and thymol as sublimating agent along with primogel as a superdisintegrant. Tablets were manufactured by direct compression method. The prepared tablets were evaluated for pre-compression and post-compression parameters result, For all formulations result was within official limits. FTIR studies revealed that there were no interactions between the drug and the excipients used. From in vitro drug release studies it was concluded that the formulations F6 and F7 containing 10% and 15% of thymol showed fast drug release of 100.00% and 100.84% respectively in 30 minutes. Formulations containing camphor (F2 & F3) and ammonium bicarbonate (F4 & F5) as sublimating agents showed a drug release of less than 80%, while the control formulation F1 having no sublimating agent showed 49.14% of drug release in 30 minutes. Thus thymol can successfully be used to formulate fast dissolving tablets of flurbiprofen by sublimation method with much better dissolution profile.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159059
10.1590/s2175-97902018000417061
url https://www.revistas.usp.br/bjps/article/view/159059
identifier_str_mv 10.1590/s2175-97902018000417061
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159059/153987
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17061
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17061
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17061
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913854439424